Burkey Joanna M. 4

4 · BED BATH & BEYOND, INC. · Filed May 18, 2026

AI-generated summary of this filing

Updated May 18, 2026

Bed Bath & Beyond Director Joanna Burkey Exercises RSUs

What Happened

Joanna M. Burkey, a director of Bed Bath & Beyond, reported derivative transactions: a grant of 35,181 restricted stock units (RSUs) on 2026-05-14 (award, code A) and the conversion/exercise of 26,873 derivative units on 2026-05-15 (exercise/conversion, code M). The report also shows 1,554 derivative units from an earlier October 7, 2025 distribution (reported as acquired).
The RSU grant is reported at $0.00 (typical for awards). Footnote F1 confirms 26,873 RSUs vested at the close of business on May 15, 2026 and vested shares were delivered promptly; the filing records a conversion/exercise and a corresponding $0.00 disposition entry consistent with settlement/delivery. Footnote F2 indicates the 35,181 RSUs granted on May 14, 2026 vest on May 14, 2027. Footnote F3 describes the 1,554 instruments as warrants issued Oct 7, 2025 with an exercise price of $15.50 each.

Key Details

Transaction dates and types: 2026-05-14 (Grant/Award — 35,181 RSUs at $0.00); 2026-05-15 (Exercise/Conversion — 26,873 derivative units converted/delivered; filing also shows a $0.00 disposition for 26,873); 2025-10-07 (acquisition of 1,554 warrants as a pro‑rata distribution).
Prices/values: awards and conversions reported at $0.00 in the Form 4 (RSUs are derivative awards; warrants have an exercise price of $15.50 per warrant if exercised).
Shares/derivatives after transactions: filing notes the 35,181 RSUs (vesting 5/14/2027) are beneficially owned following the grant; 26,873 RSUs vested and were delivered on 5/15/2026; 1,554 warrants remain from the Oct 2025 distribution.
Filing timeliness: Form 4 was filed on 2026-05-18 for transactions on 5/14–5/15/2026; the filing is reported on the Form 4 and not flagged as late.
Transaction codes: A = award/grant of RSUs; M = exercise/conversion of derivative securities.

Context

RSUs are contingent rights to receive common stock when they vest; conversion/exercise entries and $0.00 dispositions in Form 4s commonly reflect delivery/settlement of vested RSUs rather than open‑market sales. The warrants noted are separate derivative instruments that can be exercised at $15.50 per warrant.
These transactions are routine director compensation and derivative settlements; they are factual disclosures of awards vesting and conversions, not statements of intent or market opinion.

Form 4

Period: 2026-05-14

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-05-15+26,873→ 42,417 total
Award
Restricted Stock Units
[F2]
2026-05-14+35,181→ 35,181 total
→ Common Stock (35,181 underlying)
Exercise/Conversion
Restricted Stock Units
[F1]
2026-05-15−26,873→ 0 total
→ Common Stock (26,873 underlying)
Award
Common Stock Warrant
[F3]
2025-10-07+1,554→ 1,554 total
Exercise: $15.50From: 2025-12-03Exp: 2026-10-07→ Common Stock (1,554 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
[F2]Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
[F3]Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.

Signature

/s/ Christina Wheeler, Attorney-in-Fact|2026-05-18

1 file